SigTuple
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 30.0m | 30.0m | 30.0m | 15.9m | 28.2m |
% growth | - | - | - | (47 %) | 77 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
$5.8m | Series A | ||
$50.0k | Grant | ||
* | $19.0m | Series B | |
$16.0m | Series C | ||
* | $4.3m Valuation: $80.0m | Late VC | |
* | $4.0m Valuation: $80.0m | Series C | |
Total Funding | €44.7m |
Related Content
Recent News about SigTuple
EditSigTuple is a healthcare technology company leveraging artificial intelligence (AI), robotics, and data science to develop smart screening solutions. The company operates in the healthcare diagnostics market, focusing on making healthcare accurate, accessible, and affordable. SigTuple's core products include Shonit, an AI system for complete peripheral blood smear analysis; Shrava, an AI system for automated urine microscopy analysis; Aadi, a cloud-based AI system for motility and morphology analysis; and Drishti, a SaaS platform for screening diabetic retinopathy. These products are designed to assist healthcare providers in delivering standardized and scalable healthcare innovations. SigTuple primarily serves hospitals, diagnostic labs, and healthcare providers who benefit from enhanced diagnostic accuracy and efficiency. The company generates revenue through the sale and subscription of its AI-driven diagnostic platforms and services.
Keywords: AI healthcare, diagnostics, blood analysis, urine analysis, retinal screening, robotics, data science, SaaS, healthcare providers, India.